| 发明名称 |
TRANSDERMALES PFLASTER MIT BUPRENORPHIN ZUR VERWENDUNG IN DER BEHANDLUNG VON SCHMERZEN FÜR EIN DOSIERUNG-INTERVALL VON 7 TAGEN |
| 摘要 |
A sustained release formulation of buprenorphine is new. The composition comprises a transdermal delivery device which provides a first order release of buprenorphine over a 3-day dosing interval so that a maximum plasma concentration of 20 10 1052 pg/ml is obtained. the device then provides zero order kinetics over at least 2 more days. |
| 申请公布号 |
AT556682(T) |
申请公布日期 |
2012.05.15 |
| 申请号 |
AT20100185240T |
申请日期 |
1998.02.24 |
| 申请人 |
EURO-CELTIQUE S.A. |
发明人 |
REDER, ROBERT;GOLDENHEIM, PAUL;KAIKO, ROBERT |
| 分类号 |
A61F13/00;A61K9/22;A61K9/70;A61K31/00;A61K31/485;A61P25/00;A61P25/04;A61P29/00 |
主分类号 |
A61F13/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
